TENAX THERAPEUTICS, INC. Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
TENAX THERAPEUTICS, INC. (TENX) had Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One of $462.69 thousand as of 2020-12-31, per its 10-K/A filed 2021-04-16.
Discontinued › Notes › Investments › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost · last filed 2021-04-16
- 2020-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $462.69K.
- 2019-12-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $493.88K.
- 2019-06-30: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $502.13K.
- 2019-03-31: Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One $501.63K.
| Period end | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2020-12-31 | $462.69K 10-K/A · filed 2021-04-16 |
| 2019-12-31 | $493.88K 10-K/A · filed 2021-04-16 |
| 2019-06-30 | $502.13K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $501.63K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $494.63K 10-K · filed 2020-03-30 |
| 2018-09-30 | $1.51M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.50M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $3.62M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $6.12M 10-K · filed 2019-04-01 |
| 2017-09-30 | $6.77M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $6.56M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $5.50M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.28M 10-K · filed 2018-04-02 |
| 2016-09-30 | $6.76M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $8.02M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $12.51M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $16.53M 10-K · filed 2017-03-16 |
| 2015-10-31 | $16.58M 10-Q · filed 2015-12-10 |
| 2015-07-31 | $17.66M 10-Q · filed 2015-09-09 |
| 2015-04-30 | $9.20M 10-KT · filed 2016-03-14 |
| 2015-01-31 | $7.16M 10-Q · filed 2015-03-17 |
| 2014-10-31 | $8.23M 10-Q · filed 2014-12-15 |
| 2014-07-31 | $4.17M 10-Q · filed 2014-09-15 |
| 2014-04-30 | $0.00 10-K · filed 2015-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |